Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

• Jaap J. Zwaginga,
• Bronno van der Holt,
• Peter A. te Boekhorst,
• Bart J. Biemond,
• Mark-David Levin,
• René van der Griend,
• Anneke Brand,
• Sonja Zweegman,
• Hans F.M. Pruijt,
• Vera M.J. Novotny,
• Art Vreugdenhil,
• Marco R. de Groot,
• Okke de Weerdt,
• Elisabeth C.M. van Pampus,
• Tanja M. van Maanen-Lamme,
• Shulamiet Wittebol,
• Martin R. Schipperus,
• Matthijs H. Silbermann,
• Peter C. Huijgens,
• Marleen Luten,
• Rene Hollestein,
• Jan A.C. Brakenhoff,
• Jolanda G. Schrama,
• Fransje A.A. Valster,
• Gerjo A. Velders,
• Harry R. Koene

Affiliations

Jaap J. Zwaginga

Dept. of Immunohematology and Blood Transfusion, Leiden University Medical Center and the Jon J van Rood Center for Clinical Transfusion Research, Sanquin-Leiden University Medical Center, The Netherlands

Bronno van der Holt

HOVON Data Center, Erasmus MC Cancer Institute – Clinical Trial Center, Rotterdam

Peter A. te Boekhorst

Dept. of Hematology, Erasmus MC, Rotterdam

Bart J. Biemond

Dept. of Hematology, Academic Medical Center Amsterdam, The Netherlands

Mark-David Levin

Dept. of Internal Medicine, Albert Schweitzer Hospital, Dordrecht

René van der Griend

Department of Internal Medicine, Diakonessenhuis, Utrecht

Anneke Brand

Dept. of Immunohematology and Blood Transfusion, Leiden University Medical Center and the Jon J van Rood Center for Clinical Transfusion Research, Sanquin-Leiden University Medical Center, The Netherlands

Sonja Zweegman

Dept. of Hematology, VU University Medical Center, Amsterdam

Hans F.M. Pruijt

Dept. of Internal Medicine, Jeroen Bosch Hospital, Den Bosch

Vera M.J. Novotny

Dept. of Hematology, Radboud University Medical Centre, Nijmegen

Art Vreugdenhil

Dept of Internal Medicine, Máxima Medical Center, Veldhoven

Marco R. de Groot

Dept. of Internal Medicine, Medisch Spectrum Twente, Enschede

Okke de Weerdt

Dept. of Internal Medicine, St. Antonius Hospital, Nieuwegein

Elisabeth C.M. van Pampus

Dept. of Laboratory Medicine, Radboud University Medical Center, Nijmegen

Tanja M. van Maanen-Lamme

Dept. of Internal Medicine, Westfriesgasthuis, Hoorn

Shulamiet Wittebol

Dept. of Internal Medicine, Meander Hospital, Amersfoort

Martin R. Schipperus

Dept. of Internal Medicine, HagaZiekenhuis, Den Haag

Matthijs H. Silbermann

Dept. of Internal Medicine, Tergooiziekenhuizen, Blaricum

Peter C. Huijgens

Dept. of Hematology, VU University Medical Center, Amsterdam

Marleen Luten

HOVON Data Center, Erasmus MC Cancer Institute – Clinical Trial Center, Rotterdam

Rene Hollestein

HOVON Data Center, Erasmus MC Cancer Institute – Clinical Trial Center, Rotterdam

Jan A.C. Brakenhoff

Waterland hospital, Purmerend

Jolanda G. Schrama

Dept. of Internal Medicine, Spaarne hospital, Hoofddorp

Fransje A.A. Valster

Dept. of Internal Medicine, Lievensberg Hospital, Bergen op Zoom, The Netherlands

Gerjo A. Velders

Dept. of Internal Medicine, Gelderse Vallei Hospital, Ede, The Netherlands

Harry R. Koene

Dept. of Internal Medicine, St. Antonius Hospital, Nieuwegein